| Past two years | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 519 | 350 | 107 |
| Full Text Views | 11 | 1 | 0 |
| PDF Downloads | 12 | 0 | 0 |
Pentoxifylline as an ancillary treatment for severe falciparum malaria in Thailand.
S Looareesuwan
S Looareesuwan
Department of Clinical Tropical Medicine and Bangkok Hospital for Tropical Diseases, Faculty of Tropical Medicine, Mahidol University, Thailand.
Search for other papers by S Looareesuwan in
Current site
Google Scholar
PubMed
Search for other papers by S Looareesuwan in
Current site
Google Scholar
PubMed
P Wilairatana
P Wilairatana
Department of Clinical Tropical Medicine and Bangkok Hospital for Tropical Diseases, Faculty of Tropical Medicine, Mahidol University, Thailand.
Search for other papers by P Wilairatana in
Current site
Google Scholar
PubMed
Search for other papers by P Wilairatana in
Current site
Google Scholar
PubMed
S Vannaphan
S Vannaphan
Department of Clinical Tropical Medicine and Bangkok Hospital for Tropical Diseases, Faculty of Tropical Medicine, Mahidol University, Thailand.
Search for other papers by S Vannaphan in
Current site
Google Scholar
PubMed
Search for other papers by S Vannaphan in
Current site
Google Scholar
PubMed
V Wanaratana
V Wanaratana
Department of Clinical Tropical Medicine and Bangkok Hospital for Tropical Diseases, Faculty of Tropical Medicine, Mahidol University, Thailand.
Search for other papers by V Wanaratana in
Current site
Google Scholar
PubMed
Search for other papers by V Wanaratana in
Current site
Google Scholar
PubMed
C Wenisch
C Wenisch
Department of Clinical Tropical Medicine and Bangkok Hospital for Tropical Diseases, Faculty of Tropical Medicine, Mahidol University, Thailand.
Search for other papers by C Wenisch in
Current site
Google Scholar
PubMed
Search for other papers by C Wenisch in
Current site
Google Scholar
PubMed
M Aikawa
M Aikawa
Department of Clinical Tropical Medicine and Bangkok Hospital for Tropical Diseases, Faculty of Tropical Medicine, Mahidol University, Thailand.
Search for other papers by M Aikawa in
Current site
Google Scholar
PubMed
Search for other papers by M Aikawa in
Current site
Google Scholar
PubMed
G Brittenham
G Brittenham
Department of Clinical Tropical Medicine and Bangkok Hospital for Tropical Diseases, Faculty of Tropical Medicine, Mahidol University, Thailand.
Search for other papers by G Brittenham in
Current site
Google Scholar
PubMed
Search for other papers by G Brittenham in
Current site
Google Scholar
PubMed
W Graninger
W Graninger
Department of Clinical Tropical Medicine and Bangkok Hospital for Tropical Diseases, Faculty of Tropical Medicine, Mahidol University, Thailand.
Search for other papers by W Graninger in
Current site
Google Scholar
PubMed
Search for other papers by W Graninger in
Current site
Google Scholar
PubMed
W H Wernsdorfer
W H Wernsdorfer
Department of Clinical Tropical Medicine and Bangkok Hospital for Tropical Diseases, Faculty of Tropical Medicine, Mahidol University, Thailand.
Search for other papers by W H Wernsdorfer in
Current site
Google Scholar
PubMed
Search for other papers by W H Wernsdorfer in
Current site
Google Scholar
PubMed
Pentoxifylline, an inhibitor of tumor necrosis factor, has been evaluated as an antimalarial agent in combination with artesunate in 45 patients with severe falciparum malaria. Patients were admitted to the intensive care unit at the Hospital for Tropical Diseases in Bangkok, Thailand, and randomly assigned to treatment for 72 hr with a combination of intravenously administered artesunate and 1) placebo, 2) low-dose pentoxifylline (0.83 mg/kg/hr), or 3) high-dose pentoxifylline (1.67 mg/kg/hr). All 45 patients had one or more manifestations of severe malaria such as cerebral malaria (n = 18), renal failure requiring hemodialysis (n = 9), azotemia (n = 8), jaundice (n = 25), or hyperparasitemia (n = 30). The overall severity was comparable in the three groups. Clinical outcome was assessed with respect to the parasite clearance time and the fever clearance time in all patients. In addition, a number of subsidiary outcome variables were examined in specific subgroups, including the recovery time from coma for patients with cerebral malaria, the duration of intubation in patients with respiratory distress, the number of hemodialysis treatments needed for patients with acute renal failure, and the number of units of blood administered to patients requiring transfusion. Concentrations of tumor necrosis factor were reduced in all three groups at 48 hr after treatment. No significant differences among the three treatment groups were found for any of the outcome variables examined. We conclude that the addition of pentoxifylline to artesunate therapy for severe malaria produced no evident clinical benefit.
Author Notes
| Past two years | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 519 | 350 | 107 |
| Full Text Views | 11 | 1 | 0 |
| PDF Downloads | 12 | 0 | 0 |